The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease (Q28005463)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

title

The antibody aducanumab reduces Aβ plaques in Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Robert Scannevin

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

author name string

Jeff Sevigny

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Ping Chiao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Thierry Bussière

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Leslie Williams

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Marcel Maier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Robert Dunstan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Stephen Salloway

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Tianle Chen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Yan Ling

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Fang Qian

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Mahin Arastu

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Mingwei Li

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Sowmya Chollate

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Omar Quintero-Monzon

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Thomas Engber

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Kenneth Rhodes

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

James Ferrero

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Yaming Hang

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Alvydas Mikulskis

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Jan Grimm

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Christoph Hock

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Alfred Sandrock

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

John O'Gorman

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Melanie S Brennan

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

H Moore Arnold

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Roger M Nitsch

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

language of work or name

English

0 references

publication date

1 September 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

volume

537

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

page(s)

50-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

issue

7618

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

22 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Alzheimer's disease: the amyloid cascade hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Current thinking on the mechanistic basis of Alzheimer's and implications for drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

The therapeutics of Alzheimer's disease: where we stand and where we are heading

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Alzheimer's disease drug-development pipeline: few candidates, frequent failures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Amyloid PET Screening for Enrichment of Early-Stage Alzheimer Disease Clinical Trials: Experience in a Phase 1b Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Passage of amyloid beta protein antibody across the blood-brain barrier in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer's disease mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

MR imaging features of amyloid-related imaging abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Vascular alterations in PDAPP mice after anti-Aβ immunotherapy: Implications for amyloid-related imaging abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-beta immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Molecular mechanisms of amyloid oligomers toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Amyloid-β Receptors: The Good, the Bad, and the Prion Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Small Aβ1-42 oligomer-induced membrane depolarization of neuronal and microglial cells: role of N-methyl-D-aspartate receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Screening for predementia AD: time-dependent operating characteristics of episodic memory tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Revising the definition of Alzheimer's disease: a new lexicon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE19323

Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27582220

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Gantenerumab: a novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27582220

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NATURE19323

2 references

Consolidated OpenCitations Corpus – April 2017

3313614

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27582220%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

22 March 2020

1029992555

0 references

Fatcat ID

release_od3tgm45s5ctzmrc4fwb5vtfve

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/od3tgm45s5ctzmrc4fwb5vtfve

mapped directly with Wikidata item

24 November 2022

based on heuristic

3313614

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

3313614